Ignite Creation Date:
2024-05-06 @ 1:52 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01916902
Status:
WITHDRAWN
Last Update Posted:
2014-05-26
First Post:
2013-08-02
Brief Title:
Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI an OCT Study
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Effect of Pretreatment With Ticagrelor on Residual Thrombus After Percutaneous Coronary Intervention PCI in Patients Presenting With Acute Coronary Syndrome in Comparison With Delayed Treatment at the Time of PCI an Optical Coherence Tomography Study
Status:
WITHDRAWN
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Despite a large number of patients screened very few met eligibility guidelines
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Subjects presenting with probable acute coronary syndromes scheduled for cardiac catheterization will be enrolled in this study Consented subjects will be randomized to receive ticagrelor started with a loading dose immediately after enrollment versus receiving a loading dose of ticagrelor during cardiac catheterization after diagnostic angiography but prior to stenting Optical coherence tomography OCT will be performed after stenting and the volume of thrombus within the new stent will be measured and compared between the groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None